Intravenous Levetiracetam in Children With Seizures: A Prospective Safety Study
In 2006, intravenous levetiracetam received US Food and Drug Administration (FDA) approval for adjunctive treatment of partial onset seizures in adults with epilepsy, 16 years or older. We have established the safety, tolerability, and dosage of intravenous levetiracetam in children. This prospective study included 30 children (6 months to
Medical Subject Headings
Journal of Child Neurology
Digital Object Identifier (DOI)
Ng, Yu Tze; Hastriter, V.; Cardenas, Javier F.; Khoury, Emily M.; and Chapman, Kevin E., "Intravenous Levetiracetam in Children With Seizures: A Prospective Safety Study" (2010). Neurology. 38.